Never has change been more necessary in the healthcare, without a doubt. Nowadays, there are several worrying challenges affecting the sector in general. One of them is the lack of crystal-clear medical data and the patients’ fragmented records.
NHCT.io, an upcoming blockchain-powered ecosystem of Total Health, with offices in the Cayman Islands and India has announced its presale starting October 1, 2018. The presale comes with an attractive 35% bonus as an early bird offer.
Blockchain technology is mainly talked about in the context of the financial markets, but U.S law could enable it to become a requisite solution for the pharmaceutical sector as well. The Drug Supply Chain Security (DSCS) Act from 2013 constraints drug makers and supply chain offerers to batten tracking ways to shun the spread of fake drugs and fasten drug recalls.
The 2018 Demo China Autumn Summit took place in Hangzhou on September 8. Hosted by CYZONE and the Hangzhou Municipal Government, Demo China is China’s biggest high-tech demo day. This year’s event was attended by over 2000 investors, more than 200 media partners and channels, and over 3000 startup companies.
CTi (Clinical Trials Intelligence) aims to bring down the cost of medicine, as well as increase the speed of access to new medicine, by reducing development costs for the global pharmaceutical industry.
ALLIVE is an intelligent healthcare ecosystem based on blockchain technology. ALLIVE team was invited to the Ontology Mainnet Seoul Launch, during which they announced the partnership with Ontology. Mr. Eagle Zhang, co-founder and CTO of ALLIVE, discussed some of the problems plaguing the healthcare services industry and explained how ALLIVE can help tackle those issues in his speech.
According to ResearchAndMarkets.com, the global stem cell market is expected to register a CAGR of 6.3% during the forecast period of 2018-2023. It will reach USD 14.61 billion by 2023 from USD 10.75 billion in 2018.